Cell Signals Influencing Hepatic Fibrosis

被引:57
作者
Cong, Min [1 ]
Iwaisako, Keiko [1 ]
Jiang, Chunyan [1 ]
Kisseleva, Tatiana [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1155/2012/158547
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver fibrosis is the result of the entire organism responding to a chronic injury. Every cell type in the liver contributes to the fibrosis. This paper first discusses key intracellular signaling pathways that are induced during liver fibrosis. The paper then examines the effects of these signaling pathways on the major cell types in the liver. This will provide insights into the molecular pathophysiology of liver fibrosis and should identify therapeutic targets.
引用
收藏
页数:18
相关论文
共 222 条
  • [61] Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41
  • [62] Hepatic fibrosis and cirrhosis:: The (myo)fibroblastic cell subpopulations involved
    Guyot, C
    Lepreux, S
    Combe, C
    Doudnikoff, E
    Bioulac-Sage, P
    Balabaud, C
    Desmoulière, A
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (02) : 135 - 151
  • [63] Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms
    Haga, S
    Terui, K
    Zhang, HQ
    Enosawa, S
    Ogawa, W
    Inoue, H
    Okuyama, T
    Takeda, K
    Akira, S
    Ogino, T
    Irani, K
    Ozaki, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07) : 989 - 998
  • [64] Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice
    Hamzavi, Jafar
    Ehnert, Sabrina
    Godoy, Patricio
    Ciuclan, Loredana
    Weng, Honglei
    Mertens, Peter R.
    Heuchel, Rainer
    Dooley, Steven
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (5B) : 2130 - 2144
  • [65] Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis
    Harada, K.
    Shimoda, S.
    Sato, Y.
    Isse, K.
    Ikeda, H.
    Nakanuma, Y.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 157 (02) : 261 - 270
  • [66] HARPER JW, 1993, CELL, V75, P805
  • [67] Liver development and regeneration: From laboratory study to clinical therapy
    Hata, Shoji
    Namae, Misako
    Nishina, Hiroshi
    [J]. DEVELOPMENT GROWTH & DIFFERENTIATION, 2007, 49 (02) : 163 - 170
  • [68] Hayashida Tomoko, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P302
  • [69] Mechanism of action and in vivo role of platelet-derived growth factor
    Heldin, CH
    Westermark, B
    [J]. PHYSIOLOGICAL REVIEWS, 1999, 79 (04) : 1283 - 1316
  • [70] Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activation
    Hosui, Atsushi
    Kimura, Akiko
    Yamaji, Daisuke
    Zhu, Bing-mei
    Na, Risu
    Hennighausen, Lothar
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (04) : 819 - 831